Fei Wang1, Zhi-Jun Duan, Ying-Jie Sun. 1. Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Abstract
AIM: To investigate the effect of heme oxygenase-1 (HO-1) expression on immune liver fibrosis induced by cobalt protoporphyrin (CoPP) in rats. METHODS: An immune liver fibrosis model of rat was established by administering human serum albumin (HSA). The rats were divided into CoPP, liver fibrosis and normal control groups. Rats in the CoPP group received intraperitoneal CoPP concurrently with HSA. Expression of HO-1 protein was observed by Western blotting and immunohistochemistry. Hematoxylin and eosin (HE) staining was performed to assess fibrosis proliferation and distribution, proliferation extent of fibroblasts, and alterations in hepatocytes and inflammatory cells. Type I and III collagens were detected with Van Gieson's (VG) staining and Foot's reticular fiber staining, respectively. In addition, spindle-shaped cells existing at perisinusoidal locations beyond portal and septa areas were investigated with HE staining. RESULTS: Western blotting and immunohistochemistry showed that the expression of HO-1 protein was higher in the CoPP group than in the liver fibrosis group (P < 0.05). Compared with the liver fibrosis group, the serological index of hepatic fibrosis in the CoPP group decreased significantly (P < 0.05). HE, VG and Foot's staining revealed that administration of CoPP reduced the extent of hepatic fibrosis. The levels of serological indicators and the number of spindle-shaped cells at perisinuous locations beyond the portal and septa areas were reduced in the CoPP group. Only a few inflammatory cells were seen around the portal areas and central veins in the CoPP group. CONCLUSION: Increased endogenous HO-1 may suppress liver fibrosis by protecting liver cells, inhibiting inflammatory cell infiltration and hepatic stellate cell transformation.
AIM: To investigate the effect of heme oxygenase-1 (HO-1) expression on immune liver fibrosis induced by cobalt protoporphyrin (CoPP) in rats. METHODS: An immune liver fibrosis model of rat was established by administering humanserum albumin (HSA). The rats were divided into CoPP, liver fibrosis and normal control groups. Rats in the CoPP group received intraperitoneal CoPP concurrently with HSA. Expression of HO-1 protein was observed by Western blotting and immunohistochemistry. Hematoxylin and eosin (HE) staining was performed to assess fibrosis proliferation and distribution, proliferation extent of fibroblasts, and alterations in hepatocytes and inflammatory cells. Type I and III collagens were detected with Van Gieson's (VG) staining and Foot's reticular fiber staining, respectively. In addition, spindle-shaped cells existing at perisinusoidal locations beyond portal and septa areas were investigated with HE staining. RESULTS: Western blotting and immunohistochemistry showed that the expression of HO-1 protein was higher in the CoPP group than in the liver fibrosis group (P < 0.05). Compared with the liver fibrosis group, the serological index of hepatic fibrosis in the CoPP group decreased significantly (P < 0.05). HE, VG and Foot's staining revealed that administration of CoPP reduced the extent of hepatic fibrosis. The levels of serological indicators and the number of spindle-shaped cells at perisinuous locations beyond the portal and septa areas were reduced in the CoPP group. Only a few inflammatory cells were seen around the portal areas and central veins in the CoPP group. CONCLUSION: Increased endogenous HO-1 may suppress liver fibrosis by protecting liver cells, inhibiting inflammatory cell infiltration and hepatic stellate cell transformation.
Authors: Joao Seda Neto; Atsunori Nakao; Kei Kimizuka; Anna Jeanine Romanosky; Donna B Stolz; Takashi Uchiyama; Michael A Nalesnik; Leo E Otterbein; Noriko Murase Journal: Am J Physiol Renal Physiol Date: 2004-08-03
Authors: Frank A D T G Wagener; Hans-Dieter Volk; Dean Willis; Nader G Abraham; Miguel P Soares; Gosse J Adema; Carl G Figdor Journal: Pharmacol Rev Date: 2003-07-17 Impact factor: 25.468
Authors: Rong Qi Wang; Yue Min Nan; Wen Juan Wu; Ling Bo Kong; Fang Han; Su Xian Zhao; Li Kong; Jun Yu Journal: Lipids Health Dis Date: 2011-02-12 Impact factor: 3.876
Authors: Marta B Afonso; Pedro M Rodrigues; André L Simão; Dimitry Ofengeim; Tânia Carvalho; Joana D Amaral; Maria M Gaspar; Helena Cortez-Pinto; Rui E Castro; Junying Yuan; Cecília M P Rodrigues Journal: Cell Death Dis Date: 2016-09-29 Impact factor: 8.469